Market Overview:
The global bovine somatotropin (BST) market is expected to reach USD 1.5 billion by 2030, registering a CAGR of 5.1% during the forecast period 2018-2030. The growth in the market can be attributed to the increasing demand for milk and meat products, rising awareness about animal health and nutrition, and technological advancements in the field of BST production. However, factors such as stringent regulations for BST use and its high cost are restraining the growth of this market. Based on type, recombinant bovine somatotropin (rBST) accounted for a major share of the global BST market in 2017. rBST is produced through genetic engineering using bacteria or yeast cells that have been modified to produce human-like hormones known as somatotropins. It helps dairy cows produce more milk than they would naturally produce without it; however, its use is banned in some countries owing to safety concerns related to human health.
Product Definition:
Bovine Somatotropin (BST) is a protein hormone produced in the pituitary gland of cattle. It regulates the growth and metabolism of cattle.
Recombinant Bovine Somatotropin (rBST):
Recombinant Bovine Somatotropin (rBST) is a growth hormone that was developed by the recombinant DNA technology. It is widely used in dairy cattle to increase milk production and improve meat quality. rBST has no effect on humans or other animals, as it does not contain human growth hormone (GH).
The main function of rBST is to increase milk production in cows, which means more cream, butterfat.
Bovine Somatotropin:
Bovine Somatotropin (BST) is a growth hormone that is naturally produced by the bovine. It has been observed that Bovine Somatotropin increases milk production in dairy cows and helps them to recover quickly from illness & injury. The U.S., China, India, Brazil, Japan and New Zealand are the major countries where Bovine Somatropin is used on a commercial scale for improving animal health.
Application Insights:
On the basis of application, the global market has been segmented into personal and plant BST. Personal use of bovine somatotropin includes consumption by individuals for weight management and muscle development. The plant-based application segment is anticipated to witness significant growth over the forecast period owing to its wide-spread usage in various industries including dairy, meat & seafood, and pharmaceuticals.
Plant BST is used for increasing milk production in animals that are engaged in dairy farming or breeding activities. This hormone enhances protein synthesis during lactation resulting in increased milk production from cows.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017, owing to high awareness levels regarding the benefits of bovine somatotropin among dairy farmers and their families. The region is expected to maintain its dominance during the forecast period due to factors such as technological advancements, increased focus on food security, and rising concerns regarding health & hygiene amongst consumers.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to increasing awareness about bovine somatotropin among end-users such as feed manufacturers and pharmaceutical companies in China & India. In addition, favorable government regulations aimed at increasing investments from foreign players are expected to boost regional growth over next eight years.
Growth Factors:
- Increasing demand for milk and dairy products: The global population is growing at a rapid pace and so is the demand for milk and dairy products. This is expected to drive the growth of the BST market in the coming years.
- Rising awareness about the benefits of BST: The benefits of BST such as increased milk production, improved feed efficiency, and better calf health are gaining increasing attention from farmers worldwide. This is likely to boost the growth of the BST market in future.
- Growing popularity of recombinant DNA technology: Recombinant DNA technology has revolutionized livestock farming by helping farmers improve their productivity significantly. This is likely to fuelthegrowthoftheBSTmarketinfutureyearsaswell.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bovine Somatotropin (BST) Market Research Report
By Type
Recombinant Bovine Somatotropin (rBST), Bovine Somatotropin
By Application
Personal, Plant
By Companies
Elanco, LG Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Bovine Somatotropin (BST) Market Report Segments:
The global Bovine Somatotropin (BST) market is segmented on the basis of:
Types
Recombinant Bovine Somatotropin (rBST), Bovine Somatotropin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Personal, Plant
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Elanco
- LG Life Sciences
Highlights of The Bovine Somatotropin (BST) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Recombinant Bovine Somatotropin (rBST)
- Bovine Somatotropin
- By Application:
- Personal
- Plant
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bovine Somatotropin (BST) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
BST is a hormone produced by cows that helps to increase milk production.
Some of the key players operating in the bovine somatotropin (bst) market are Elanco, LG Life Sciences.
The bovine somatotropin (bst) market is expected to grow at a compound annual growth rate of 5.1%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bovine Somatotropin (BST) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Bovine Somatotropin (BST) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Bovine Somatotropin (BST) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Bovine Somatotropin (BST) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Bovine Somatotropin (BST) Market Size & Forecast, 2018-2028 4.5.1 Bovine Somatotropin (BST) Market Size and Y-o-Y Growth 4.5.2 Bovine Somatotropin (BST) Market Absolute $ Opportunity
Chapter 5 Global Bovine Somatotropin (BST) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bovine Somatotropin (BST) Market Size Forecast by Type
5.2.1 Recombinant Bovine Somatotropin (rBST)
5.2.2 Bovine Somatotropin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bovine Somatotropin (BST) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bovine Somatotropin (BST) Market Size Forecast by Applications
6.2.1 Personal
6.2.2 Plant
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bovine Somatotropin (BST) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bovine Somatotropin (BST) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bovine Somatotropin (BST) Analysis and Forecast
9.1 Introduction
9.2 North America Bovine Somatotropin (BST) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bovine Somatotropin (BST) Market Size Forecast by Type
9.6.1 Recombinant Bovine Somatotropin (rBST)
9.6.2 Bovine Somatotropin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bovine Somatotropin (BST) Market Size Forecast by Applications
9.10.1 Personal
9.10.2 Plant
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bovine Somatotropin (BST) Analysis and Forecast
10.1 Introduction
10.2 Europe Bovine Somatotropin (BST) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bovine Somatotropin (BST) Market Size Forecast by Type
10.6.1 Recombinant Bovine Somatotropin (rBST)
10.6.2 Bovine Somatotropin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bovine Somatotropin (BST) Market Size Forecast by Applications
10.10.1 Personal
10.10.2 Plant
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bovine Somatotropin (BST) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bovine Somatotropin (BST) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bovine Somatotropin (BST) Market Size Forecast by Type
11.6.1 Recombinant Bovine Somatotropin (rBST)
11.6.2 Bovine Somatotropin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bovine Somatotropin (BST) Market Size Forecast by Applications
11.10.1 Personal
11.10.2 Plant
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bovine Somatotropin (BST) Analysis and Forecast
12.1 Introduction
12.2 Latin America Bovine Somatotropin (BST) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bovine Somatotropin (BST) Market Size Forecast by Type
12.6.1 Recombinant Bovine Somatotropin (rBST)
12.6.2 Bovine Somatotropin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bovine Somatotropin (BST) Market Size Forecast by Applications
12.10.1 Personal
12.10.2 Plant
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bovine Somatotropin (BST) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bovine Somatotropin (BST) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bovine Somatotropin (BST) Market Size Forecast by Type
13.6.1 Recombinant Bovine Somatotropin (rBST)
13.6.2 Bovine Somatotropin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bovine Somatotropin (BST) Market Size Forecast by Applications
13.10.1 Personal
13.10.2 Plant
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bovine Somatotropin (BST) Market: Competitive Dashboard
14.2 Global Bovine Somatotropin (BST) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Elanco
14.3.2 LG Life Sciences